Rachelle JacquesCEO at Enzyvant
Rachelle joined Enzyvant as CEO from Alexion Pharmaceuticals, Inc., where she most recently served as Senior Vice President and Global Franchise Head of Complement across therapeutic areas of hematology, nephrology, and neurology. She brings broad experience in US and Global commercial leadership, including multiple high-profile product launches in rare diseases. Previously, Rachelle was Vice President of US Hematology Marketing at Shire and Baxalta, and Vice President, Business Operations for the Global Bioscience Business Unit at Baxter International. Rachelle has lived and worked in the US, Belgium, and China. She started her career in finance and has a BA in Business Administration with an emphasis in accounting from Alma College. Rachelle also serves on the boards of Corbus Pharmaceuticals and Viela Bio.